Central Sensitization Inventory (CSI): Assessing Chronic Pain and Related Disorders

The Central Sensitization Inventory (CSI) is a crucial tool for identifying symptoms related to central sensitisation, a condition where the central nervous system becomes hypersensitive. The CSI is used in both clinical and research settings to assess the severity of these symptoms. It comprises two main parts: Part A assesses 25 health-related symptoms, and Part B evaluates previous diagnoses of certain disorders. The questionnaire uses a 5-point Likert scale, ranging from "never" to "always", to measure the frequency of symptoms. Healthcare professionals can use the CSI to inform treatment decisions and monitor patient progress over time. By understanding the degree of central sensitisation, clinicians can develop targeted interventions to manage symptoms and improve patient outcomes. The CSI is an important assessment tool for conditions such as fibromyalgia and chronic pain, allowing for a more nuanced understanding of patient experiences and facilitating effective care. Its application is straightforward, making it a valuable resource in various healthcare settings. As a result, the CSI plays a key role in enhancing patient care and guiding further research into central sensitisation.